RSS

female sexual dysfunction (FSD)

Catalent Pharma Solutions has announced a commercial supply agreement with Palatin Technologies to globally launch Palatin’s bremelanotide pen injector product, which is used to treat female sexual dysfunction (FSD) more

1 Jul 2016 11:31 News